Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications

Abstract

A 9-year-old boy was admitted to our institution with acute onset of bilateral blurry vision. Physical examination revealed bilateral papilledema. Cerebrospinal fluid analysis and comprehensive metabolic panel were normal. Magnetic resonance imaging (MRI) of the brain showed extensive bilateral optic nerve inflammation with post-contrast gadolinium enhancement on T1-weighted sequence. The involvement was limited to the anterior segments of the optic nerves sparing chiasma and optic tracts. Anti-aquaporin-4 antibody (AQP4) was negative while anti-myelin oligodendrocyte glycoprotein antibody (MOG) was positive. After intravenous methylprednisolone, his vision dramatically improved. The patient was discharged with only mildly impaired visual acuity, 2 weeks after admission. Follow-up brain MRI and MOG assay after 3 months were within normal limits.

Keywords

MRI - myelin oligodendrocyte glycoprotein - optic neuritis

Publication History

Received: 07 December 2019

Accepted: 05 March 2020

Article published online:
19 July 2021

• References

• 1 Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease. J Neurol 2019; 266: 1280-6
• 2 Cellina M, Fetoni V, Ciocca M, Pirovano M, Oliva G. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review. Neuroradiol J 2018; 31: 69-82
• 3 Denève M, Biotti D, Patsoura S, Ferrier M, Meluchova Z, Mahieu L. et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol 2019; 46: 312-8
• 4 Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP. et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 2015; 15: 1-13
• 5 Biotti D, Bonneville F, Tournaire E, Ayrignac X, Dallière CC, Mahieu L. et al. Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. J Neurol 2017; 264: 2173-5
• 6 Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-17
• 7 Sato DK, Callegaro D, Lana-Peixoto MA, Water PJ, De H, Jorge FM. et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-81
• 8 Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H. et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: A comparative study. J Neurol Neurosurg Psychiatry 2016; 87: 446-8
• 9 Carra-Dalliere C, Menjot de Champfleur N, Ayrignac X, Labauge P. Optic chiasm and oculomotor nerves involvement in active multiple sclerosis. J Neuroradiol 2020; 47: 62-4
• 10 Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga AS, Fryer JP, Leavitt JA. et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: Clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 2018; 195: 8-15
• 11 Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K. et al. MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016; 13: 280
• 12 Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A. et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2015; 2: e163